Literature DB >> 6974787

The internal mammary artery graft. Its longevity after coronary bypass.

A J Tector, T M Schmahl, B Janson, J R Kallies, G Johnson.   

Abstract

Two hundred ninety-eight patients who received internal mammary artery (IMA) grafts were reviewed seven to nine years after surgery; 91.6% of these patients are still alive. In 29.5% of these patients there was postoperative graft visualization, and 90% of the studies were performed because of suspected graft failure. Attrition of the IMA graft was minimal. At zero to 24 months after surgery, 93.4% of grafts were patent. At 60 to 108 months 94.4% were patent and there was little, if any, evidence of atherosclerosis in the IMAs. Precise technique in preparation and anastomosis of the IMA is essential for long-term patency. For bypassing obstructive lesions, we recommend selection of the IMA (if it has sufficient size and flow) for use in the left anterior descending, large diagonal, or marginal vessel in the left coronary artery circulation.

Entities:  

Mesh:

Year:  1981        PMID: 6974787

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  15 in total

1.  Left internal mammary graft stenosis and restenosis following angioplasty and stenting.

Authors:  C G Spencer; G Y Lip
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

Review 2.  Pedicled or skeletonized? A review of the internal thoracic artery graft.

Authors:  Carlos Del Campo
Journal:  Tex Heart Inst J       Date:  2003

Review 3.  The comparative efficacy of percutaneous and surgical coronary revascularization in 2009: a review.

Authors:  Stephen A May; James M Wilson
Journal:  Tex Heart Inst J       Date:  2009

4.  Development of severe string sign in internal thoracic arterial graft during first month.

Authors:  Nobuaki Hirata; Nobuaki Asaoka; Akira Amemiya; Shinichi Hatsuoka; Takayoshi Ueno
Journal:  J Med Ultrason (2001)       Date:  2006-09       Impact factor: 1.314

5.  Determinants of 10-year survival after primary myocardial revascularization.

Authors:  D M Cosgrove; F D Loop; B W Lytle; C C Gill; L A Golding; C Gibson; R W Stewart; P C Taylor; M Goormastic
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

Review 6.  Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.

Authors:  J M Wilson; J J Ferguson
Journal:  Tex Heart Inst J       Date:  1995

7.  A pathohistological and biochemical study of arteriosclerosis in the internal thoracic artery, a vessel commonly used as a graft in coronary artery bypass surgery.

Authors:  H Kobayashi; S Kitamura; K Kawachi; R Morita; Y Konishi; M Tsutsumi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

8.  [Percutaneous coronary intervention versus bypass surgery in patients with diabetes and multivessel coronary disease. Coronary revascularization after FREEDOM].

Authors:  R Dörr; J Stumpf; J Dalibor; G Simonis; S G Spitzer
Journal:  Herz       Date:  2014-05       Impact factor: 1.443

9.  Atherosclerosis and the internal mammary arteries.

Authors:  R N Singh
Journal:  Cardiovasc Intervent Radiol       Date:  1983       Impact factor: 2.740

10.  Internal mammary artery versus saphenous vein graft. Comparative performance in patients with combined revascularisation.

Authors:  R N Singh; J A Sosa; G E Green
Journal:  Br Heart J       Date:  1983-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.